Adiponectin Level and Gene Variability Are Obesity and Metabolic Syndrome Markers in a Young Population

Archives of Medical Research

Volumn 43, Issue 2, 2012, Pages 145-153

  Karmelić, Ivana ^a   Lovrić, Jasna ^a   Božina, Tamara ^a   Ljubić, Hana ^b   Vogrinc, Željka ^b   Božina, Nada ^b   Sertić, Jadranka ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

Adiponectin; Gene polymorphism; Metabolic syndrome; Obesity; Young population

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADIPOQ GENE; ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; REAL TIME POLYMERASE CHAIN REACTION;

ADIPONECTIN; ADULT; CROATIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84860625807     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.02.004     Document Type: Article

References (63)

1. Obesity: preventing and managing the global epidemic 2000, World Health Organization, WHO Technical Report Series, Geneva, p. 894.
2. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006, 580:2917-2921.
3. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the MS: an American Heart Association/National Heart, Lung, and Blood Institute. Circulation 2005, 112:2735-2752.
4. Bralić I., Tahirović H., Matanić D. Growth and obesity in 7-year-old Croatian children: secular changes from 1991-2008. Eur J Pediatr 2011, 10.1007/s00431-011-1470-1.
5. FiŠter K., Kolčić I., Musić Milanović S., et al. Increased body weight in Croatia. Coll Antropol 2009, 33(suppl 1):25-29.
6. Yang W., Kelly T., He J. Genetic epidemiology of obesity. Epidemiol Rev 2007, 29:46-61.
7. Bell C.G., Walley A.J., Froguel P. The genetics of human obesity. Nat Rev Genet 2005, 6:221-234.
8. Visvikis-Siest S., Siest G. The Stanislas Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases. Clin Chem Lab Med 2008, 46:733-747.
9. Grundy S.M. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 2006, 5:295-309.
10. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome: epidemiology, mechanisms, and therapy. Lancet 2005, 365:1415-1428.
11. Mantzoros C.S., Li T., Manson J.E., et al. Circulating adiponectin levels are associated with better glycemic control, more favourable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005, 90:4542-4548.
12. Gable D.R., Hurel S.J., Humphries S.E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 2006, 188:231-244.
13. Kawano J., Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr 2009, 4:44-49.
14. Okamoto Y., Kihara S., Funahashi T., et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci 2006, 110:267-278.
15. Heid I.M., Wagner S.A., Gohlke H., et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006, 55:375-384.
16. Henneman P., Aulchenko Y.S., Frants R.R., et al. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 2008, 45:572-577.
17. Takahashi M., Arita Y., Yamagata K., et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000, 24:861-868.
18. Henneman P., Aulchenko Y.S., Frants R.R., et al. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care 2010, 33:908-913.
19. Kissebah A.H., Sonnenberg G.E., Myklebust J., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000, 97:14478-14483.
20. Vasseur F., Helbecque N., Dina C., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002, 11:2607-2614.
21. Yang W.S., Chuang L.M. Human genetics of adiponectin in the metabolic syndrome. J Mol Med 2006, 84:112-121.
22. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation of Obesity; Geneva.
23. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 1997, 366:1059-1062.
24. Priručnik o preporučenim metodama u medicinsko-biokemijskim laboratorijima 1998, Hrvatska komora medicinskih biokemičara, HKMB, Zagreb.
25. Friedwald W.T., Levy R.I., Fredricson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
26. Blüher M., Brennan A.M., Kelesidis T., et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 2007, 30:280-285.
27. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
28. Schwarz P.E., Towers G.W., Fischer S., et al. Hypoadiponectimia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006, 29:1645-1650.
29. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25:115-121.
30. Guo S.W., Thompson E.A. Performing the exact test of Hardy-Weinberg proportions for multiple alleles. Biometrics 1992, 48:361-372.
31. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): An Integrated Software Package for Population Genetics Data Analysis, Evol. Bioinform Online 2005, 1:47-50.
32. Kolcic I., PolaŠek O., Vuletić S. Scale and dynamics of overweight and obesity epidemic in Croatia. Obes Facts 2010, 3:333.
33. Guilherme A., Virbasius J.V., Vishwajeet P., et al. Adipocite dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev 2008, 9:367-377.
34. Povel C.M., Boer J.M., Reiling E., et al. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 2011, 12:952-967.
35. Khunti K., Davies M. Metabolic syndrome. BMJ 2005, 331:1153-1154.
36. Siitonen N., Pulkkinen L., Lindström J., et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 2011, 12:5.
37. Kishida K., Funahashi T., Matsuzawa Y. Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2011, 25.
38. BenAli S., Jemaa R., Ftouhi B., et al. Adiponectin and metabolic syndrome in a Tunisian population. Inflammation 2011, [Epub ahead of print].
39. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975-981.
40. Rubin D.A., McMurray R.G., Harrell J.S., et al. The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism 2008, 57:683-690.
41. Yukihiro Y., Hiroshi H., Ikuo S., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 2002, 103:137-142.
42. Kozłowska A., Kowalska I. The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease. Endokrynol Pol 2006, 57:626-632.
43. Snehalatha C., Yamuna A., Ramachandran A. Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in nondiabetic Asian Indian teenagers. Diabetes Care 2008, 31:2374-2379.
44. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
45. Huang K.C., Chen C.L., Chuang L.M., et al. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 2003, 88:4130-4134.
46. Adamczak M., Wiecek A., Funahashi T., et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hyperten 2003, 16:72-75.
47. Gong M., Long J., Liu Q., Deng H.C. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol Cell Endocrinol 2010, 325:78-83.
48. Park J.W., Park J., Jee S.H. ADIPOQ gene variants associated with susceptibility to obesity and low serum adiponectin levels in healthy Koreans. Epidemiol Health 2011, 33:1-7.
49. Heid I.M., Henneman P., Hicks A., et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
50. Tanko L.B., Siddiq A., Lecoeur C., et al. ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. Obes Res 2005, 13:2113-2121.
51. Warodomwichit D., Shen J., Arnett D.K., et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity 2009, 17:510-517.
52. Vionnet N., Hani E.H., Dupont S., et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67:1470-1480.
53. Sutton B.S., Weinert S., Langefeld C.D., et al. Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study. Hum Genet 2005, 117:107-118.
54. Petrone A., Zavarella S., Caiazzo A., et al. The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity 2006, 14:1498-1504.
55. Jang Y., Chae J.S., Koh J.S., et al. The influence of the adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin Chim Acta 2008, 391:85-90.
56. Jee S.H., Sull J.W., Lee J.E., et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet 2010, 87:545-552.
57. Ling H., Waterworth D.M., Stirnadel H.A., et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: The GEMS Study. Obesity 2009, 17:737-744.
58. Moller D.E., Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005, 56:45-62.
59. Lara-Castro C., Luo N., Wallace P., et al. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55:249-259.
60. Conneely K.N., Silander K., Scott L.J., et al. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 2004, 47:1782-1788.
61. Cai G., Cole S.A., Freeland-Graves J.H., et al. Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: The San Antonio Family Heart Study. Hum Biol 2004, 76. 651-565.
62. McQueen M.B., Bertram L., Rimm E.B., et al. QTL genome scan of the metabolic syndrome and its component traits. BMC Genet 2003, 4:S96.
63. Arya R., Blangero J., Williams K., et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 2002, 51:841-847.